The documented role of pharmacogenetic: in the identification and administration of new medications for treating drug abuse.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  NIDA research monograph

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Psychology

• Identifiers
  PMID 9066815
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Amitriptyline Bupropion Barbiturates Codeine Alprazolam Nabumetone Methadone Topiramate Tramadol Midazolam Desipramine Ketamine Diazepam Meperidine Cyclosporine Tizanidine Testosterone Amitriptyline Oxycodone Sildenafil Imipramine Imipramine Hydrocodone Indinavir Acetaminophen 2 C 9 Clomipramine Dex

  2013cites this paper
• Genetic Testing in Pain Medicine

  2013cites this paper
• Genetic testing for enzymes of drug metabolism: does it have clinical utility for pain medicine at the present time? A structured review.

  2004cites this paper
• Effects of HIV triple therapy on methadone levels.

  2002cites this paper
• The involvement of cytochrome P450 3A4 in the N-demethylation of L-alpha-acetylmethadol (LAAM), norLAAM, and methadone.

  1997cites this paper
• Determination of methadone and its N-demethylation metabolites in biological specimens by GC-PICI-MS.

  1996cites this paper